Short answer: FDA-approved brand and generic ED pills share the same premarket bioequivalence standards. Compounded sildenafil or tadalafil is legal under Section 503A but is not an NDA/ANDA-approved product — and has not gone through that same FDA review.
"Generic Viagra" and "compounded sildenafil" get used almost interchangeably in marketing, but they're regulated in fundamentally different ways. Here's the actual distinction between brand-name, FDA-approved generic, and compounded versions of these drugs.
How Brand-Name Drugs Get Approved
Viagra and Cialis went through the FDA's New Drug Application (NDA) process, which requires the manufacturer to submit clinical trial data proving safety and efficacy before the FDA approves the specific product.[1] Sildenafil was approved as Viagra in March 1998; tadalafil was approved as Cialis in November 2003 — both as branded, patent-protected products.[2]
What Happens When Patents Expire
Once a brand-name drug's patents and regulatory exclusivity expire, other manufacturers can seek FDA approval to sell the same drug through an Abbreviated New Drug Application (ANDA). This pathway doesn't require new clinical trials, but it does require the generic manufacturer to demonstrate bioequivalence to the original brand-name product.[3] Generic sildenafil (25 mg and 50 mg) became eligible for approval on August 24, 2020, once the relevant Viagra patents and exclusivity periods expired.[5] For tadalafil, FDA records show the agency moved toward approving the first generic manufacturer around May 2018, tied to the expiration of a pediatric exclusivity period on the compound patent, with that generic launching across all approved strengths in September 2018.[4]
Whether brand-name or FDA-approved generic, both versions have to meet the same FDA standards for identity, strength, quality, and purity — that's exactly what ANDA approval requires by demanding bioequivalence to the reference product.[6]
This is where compounded medication is different. Compounded sildenafil or tadalafil — including combination formulations, troches, dissolvable tablets, or non-standard doses not available in FDA-approved products — is not manufactured under an NDA or an ANDA and is not an FDA-approved product at all. It's prepared by a state-licensed pharmacy for an individual patient under a physician's prescription, following the framework in Section 503A of the Federal Food, Drug and Cosmetic Act.[6]
What Compounding Exempts a Pharmacy From
Under Section 503A, compounding pharmacies are exempt from three specific requirements that apply to FDA-approved drugs: the drug approval process itself, FDA-approved labeling with adequate directions for use, and current Good Manufacturing Practice (cGMP) standards.[6]In practice, that means a compounded sildenafil or tadalafil product hasn't been reviewed by the FDA for safety, efficacy, or manufacturing quality the way the original branded or ANDA-approved generic product has.[6] The cGMP exemption specifically applies when a licensed pharmacist or physician compounds for an identified individual patient — meaning quality control operates under a structurally different standard than FDA-regulated manufacturing facilities use.[7]
Compounding pharmacies aren't operating outside the law when they make these products, though. A bulk drug substance can be used in 503A compounding if it's a component of an FDA-approved drug, matches a recognized USP or National Formulary standard, or appears on FDA's official 503A bulk substances list — and since both sildenafil and tadalafil are already components of FDA-approved products, compounding pharmacies can generally use them under this pathway.[8]
The Bottom Line
FDA-approved generic sildenafil and tadalafil — the kind you'd get from a standard retail or mail-order pharmacy with FDA-reviewed labeling — carry the same premarket safety and efficacy review as their brand-name counterparts. Compounded versions of the same drugs don't carry that same review, regardless of how they're marketed or delivered. That doesn't make compounded medication illegitimate — it's a long-standing, legal part of medicine — but it's a meaningfully different regulatory category, and it's reasonable to expect any provider to be clear about which one you're getting.
Ask directly whether a provider is prescribing an FDA-approved generic or a compounded formulation — and compare pharmacy transparency on RENVA's Men's Health / TRT hub before choosing.
Sources
- VIAGRA (sildenafil citrate) — Full Prescribing Information — U.S. Food and Drug Administration accessdata.fda.gov
- CIALIS (tadalafil) tablets, for oral use — Full Prescribing Information — U.S. Food and Drug Administration accessdata.fda.gov
- ANDA 090141 ANDA Approval Letter — U.S. Food and Drug Administration accessdata.fda.gov
- Tadalafil Tentative Approval Letter, ANDA 209539 — U.S. Food and Drug Administration accessdata.fda.gov
- Paragraph IV Patent Certifications — U.S. Food and Drug Administration fda.gov
- Regulatory Framework for Human Drug Compounding — U.S. Food and Drug Administration fda.gov
- FD&C Act Provisions that Apply to Human Drug Compounding — U.S. Food and Drug Administration fda.gov
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act — U.S. Food and Drug Administration fda.gov
Frequently Asked Questions
Is compounded sildenafil the same as generic sildenafil?
No. FDA-approved generic sildenafil goes through the ANDA process and must demonstrate bioequivalence to Viagra. Compounded sildenafil isn't reviewed by the FDA at all — it's prepared by a pharmacy under Section 503A.[6]
Is compounded ED medication legal?
Yes — compounding under Section 503A is a legal, long-standing part of medicine, and sildenafil and tadalafil both qualify as substances pharmacies can generally compound with.[8]
Why would someone choose compounded medication over generic?
Compounded formulations can offer options not available in standard FDA-approved products, like combination formulations, alternate dosage forms, or non-standard doses.[6]
Do generic and brand-name versions meet the same quality standards?
Yes — FDA-approved generics must demonstrate bioequivalence and meet the same standards for identity, strength, quality, and purity as the brand-name reference product.[6]